Interparfums Files 8-K on Financials
Ticker: IPAR · Form: 8-K · Filed: Jan 22, 2025 · CIK: 822663
| Field | Detail |
|---|---|
| Company | Interparfums Inc (IPAR) |
| Form Type | 8-K |
| Filed Date | Jan 22, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $1.45 billion, $5, $0.07 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Interparfums dropped an 8-K detailing its financials and operations.
AI Summary
Interparfums, Inc. filed an 8-K on January 22, 2025, reporting on its results of operations and financial condition. The filing also included Regulation FD disclosures and financial statements and exhibits. The company, incorporated in Delaware, is primarily involved in the fragrance and cosmetics industry.
Why It Matters
This filing provides investors with crucial updates on Interparfums' financial performance and operational status, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial disclosure filing with no immediate negative or positive news indicated.
Key Players & Entities
- Interparfums, Inc. (company) — Registrant
- January 22, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 551 Fifth Avenue, New York, NY 10176 (address) — Principal Executive Offices
- 212.983.2640 (phone_number) — Business Phone
FAQ
What specific financial information is being disclosed in this 8-K?
The 8-K indicates disclosure regarding 'Results of Operations and Financial Condition', 'Regulation FD Disclosure', and 'Financial Statements and Exhibits'.
When was this 8-K report filed?
The report was filed on January 22, 2025.
What is Interparfums, Inc.'s principal executive office address?
The principal executive offices are located at 551 Fifth Avenue, New York, NY 10176.
In which state was Interparfums, Inc. incorporated?
Interparfums, Inc. was incorporated in Delaware.
What is the SIC code for Interparfums, Inc.?
The Standard Industrial Classification (SIC) code for Interparfums, Inc. is 2844, which corresponds to 'Perfumes, Cosmetics & Other Toilet Preparations'.
Filing Stats: 654 words · 3 min read · ~2 pages · Grade level 9.9 · Accepted 2025-01-22 16:56:57
Key Financial Figures
- $1.45 billion — relating to achieving the sales goal of $1.45 billion which positions the Company to meet its
- $5 — 24 earnings per diluted share target of $5.15, excluding a supplemental non-recurr
- $0.07 — cash impairment charge of approximately $0.07 per diluted share, associated with our
Filing Documents
- ipar-20250122.htm (8-K) — 32KB
- ex991_1.htm (EX-99.1) — 48KB
- img673cbb5cf4ed4fd98b22.jpg (GRAPHIC) — 6KB
- 0001753926-25-000118.txt ( ) — 216KB
- ipar-20250122_def.xml (EX-101.DEF) — 1KB
- ipar-20250122_pre.xml (EX-101.PRE) — 12KB
- ipar-20250122_cal.xml (EX-101.CAL) — 1KB
- ipar-20250122_lab.xml (EX-101.LAB) — 16KB
- ipar-20250122.xsd (EX-101.SCH) — 4KB
- ipar-20250122_htm.xml (XML) — 3KB
02 Results of Operations and Financial Conditions
Item 2.02 Results of Operations and Financial Conditions Certain portions of our press release dated January 22, 2025, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows: The 1 st , 2 nd (consisting of a table), 3 rd , and 5 th through 12 th full paragraphs relating to net sales for the fourth quarter of 2024 or the full year ended December 31, 2024. The portion of the 4 th paragraph relating to net sales for the fourth quarter of 2024 or the full year ended December 31, 2024. The 14 th paragraph relating to achieving the sales goal of $1.45 billion which positions the Company to meet its full year 2024 earnings per diluted share target of $5.15, excluding a supplemental non-recurring, non-cash impairment charge of approximately $0.07 per diluted share, associated with our trademarks.
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure Certain portions of our press release dated January 22, 2025, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01. They are as follows: Portion of the 4 th paragraph relating to potential future Guess sales levels The 13 th paragraph relates to limited 2025 visibility, potential future demand, and strong product pipelines for 2025 The 15 th paragraph relating to plans to release 2025 guidance and 2024 fourth quarter and full year consolidated results The 16 th through 19 th paragraphs relating to the conference call scheduled for February 25, 2025 The 22 nd paragraph relating to forward-looking information The balance of such press release not otherwise incorporated by reference in Item 2.02.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits . 99.1 Our press release dated January 22 , 2025
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned. Dated: January 22, 2025 Interparfums, Inc. By: /s/ Michel Atwood Michel Atwood Chief Financial Officer